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Hypereosinophilic syndrome (HES) is characterized by an overproduction of eosinophils that leads to organ damage.
Although most cases of HES frequently affect the lungs, heart, and gastrointestinal tract, there are a few reported cases
of peripheral vascular involvement. We report a case of a patient with a history of colonic HES who presented with
idiopathic occlusion of the brachial artery. A 28-year-old woman with a recent history of eosinophilic colitis presented
with a several-week history of left hand pain, pallor, and paresthesias. Her hand was cool, without palpable pulses. Her
eosinophilia count was 38%. An arteriogram documented a left brachial artery occlusion and diffuse left arm vasospasm.
A brachial-to-brachial bypass was performed. Postoperatively, there was extensive vasospasm of her distal upper extremity
arteries, which was treated with calcium-channel blockers and steroids. Her symptoms resolved and she has been
asymptomatic for 9 months. The segment of occluded artery was found to contain many eosinophils on histologic
examination.HES of the arterial system is an exceedingly rare cause of occlusion. Our patient presented with eosinophilia,
arterial vasospasm with subsequent occlusion, and the presence of eosinophilic infiltration on the pathologic specimen.
These data, combined with the patient’s previous history, demonstrate that the patient’s occlusion may have been
secondary to HES. (J Vasc Surg 2005;42:796-9.)Hypereosinophilic syndrome (HES) refers to a group
of leukoproliferative disorders characterized by an overpro-
duction of eosinophils that leads to organ damage. The
diagnosis of HES requires a sustained eosinophil count of
1500 cells/mL for 6 months without any other obvi-
ous cause of eosinophilia. Patients must also have signs and
symptoms of organ involvement.
HES may affect any organ in the body, and the clinical
manifestations can vary. HES of the cardiac system most
commonly leads to congestive heart failure secondary to
endomyocardial fibrosis. Neurologic manifestations in-
clude embolic or thrombotic strokes and transient ischemic
attacks that are secondary to HES cardiac involvement or
an idiopathic hypercoagulable state. Involvement of the
hematologic system entails splenomegaly with left upper-
quadrant pain. When the pulmonary system becomes in-
volved, patients usually experience a persistent cough or
dyspnea. Rheumatologic symptoms can also be present and
include arthralgias and myalgias. When the gastrointestinal
system is affected, the symptoms are usually nonspecific and
include nausea, vomiting, or abdominal pain. Constitutional
symptoms of fever, night sweats, anorexia, and weight loss are
also associated with the systemic nature of HES.1
Most cases of HES frequently affect the lungs, heart,
and gastrointestinal tract, although a few cases of peripheral
vascular involvement have been reported.2-9 Many of these
cases are secondary to angiolymphoid hyperplasia, how-
ever. Angiolymphoid hyperplasia is an uncommon condi-
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796tionmanifested by skin plaques and nodules in the head and
neck area. On biopsy, angiolymphoid hyperplasia has a
distinct histologic description, including highly prolifera-
tive blood vessels, large endothelial cells, and inflammatory
infiltrates with eosinophils within the blood vessels. We
report a case of a patient with a history of colonic HES who
presented with idiopathic occlusion of the brachial artery
and histologic evidence of leukoproliferation with eosino-
philia.
CASE REPORT
A 28-year-old woman with a recent history of eosino-
philic colitis presented with left hand pain. The patient had
presented 1 year earlier with diarrhea and abdominal pain.
Colonoscopy demonstrated an inflamed segment of colon
with eosinophilic infiltration and hypereosinophilia on a
complete blood count. A diagnosis of HES was made. She
was treated with steroids, with resolution of her symptoms
for approximately 9 months. A recurrent episode of similar
abdominal pain and diarrhea occurred later and resolved
with steroids.
One month after this second flare-up, the patient pre-
sented with a 4-month history of left hand pain with
periods of numbness and pallor. The symptoms were not
related to any particular season, activity, time of day, tem-
perature, or medication. She denied any history of trauma,
including any recent vascular interventions or catheter
placements. She also denied tobacco use or any significant
past medical history.
On physical exam, the patient’s left hand was blue,
cool, and edematous. Sensation to pain, temperature, and
soft touch were intact. She had a faintly palpable brachial
artery pulse, but the radial and ulnar arteries were not
palpable. An angiogram revealed complete occlusion of
the midpoint of the brachial artery with reconstitution
lete o
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(200 g) was given directly into the brachial artery, but the
artery did not dilate. Attempts to cross the occluded seg-
ment with guidewires were unsuccessful. There was no
evidence of atherosclerotic or other peripheral vascular
disease (Fig 1).
The patient had a significantly elevated eosinophilia
count of 38% and an absolute eosinophil count of 8.53 
103 (white blood cell count, 22.45  103). The patient’s
hypercoaguable workup was normal and included pro-
thrombin time/partial thromboplastin time, antiphospho-
lipid antibodies (lupus anticoagulants and anticardiolipin
antibodies), and factor V Leiden mutation. The patient had
normal levels of homocysteine, protein C, and protein S.
High-dose steroid therapy was initiated based on this
patient’s past response to steroids. The patient’s eosinophil
count decreased to a normal level of 4%; however, her
symptoms did not improve. A left brachial-to-brachial ar-
tery bypass graft with a saphenous vein graft was performed.
At the time of surgery, the occluded segment was small and
thickened, suggesting chronic disease.
On postoperative day 1, the bypass occluded. Arterial
flow was restored after a thrombectomy, but an intraoper-
ative angiography showed diffuse vasospasm distal to the
bypass. Paperavine and nitroglycerin were injected into the
brachial artery, and intravenous nicardipine was adminis-
tered systemically. Following this, the patient was noted to
have palpable radial and ulnar arteries. Postoperatively, the
patient tolerated this arterial bypass revision without com-
plications and had minimal hand pain and numbness. She
was discharged on postoperative day 5 on a regimen of
nicardipine, Coumadin (DuPont Merck Pharma, Wilming-
ton, Del), and prednisone.
On pathology, the cross sections of the artery demon-
strated acute thrombosis in varying stages of organization.
Some areas demonstrated early angiogenesis with small
capillary channels extending into the base of the thrombus
adjacent to the vessel wall. In these areas of organization
Fig 1. An angiogram shows compadjacent to the intima, a slight accumulation of mononu-clear leukocytes was near, but not penetrating, the vessel
wall. The thrombotic material was noted to contain scat-
tered eosinophils. In areas where the thrombus was adher-
ing to the vessel wall, the intima showed reactive changes
associated with endothelial swelling. In areas where the
thrombus was not adhering to the artery wall, the endothe-
lial surface and intima were unremarkable. There was no
inflammation or other histologic abnormalities in the me-
dia of the artery. There was no evidence of arteriosclerosis
or atherosclerosis. There was significant infiltration of eo-
sinophils and a prominence of small vascular channels in the
adventitia. These changes persisted in the arterial wall re-
gardless of the presence or absence of thrombus (Fig 2).
The pathology was interpreted as recent thrombus with
cclusion of the left brachial artery.
Fig 2. High-magnification view of the inner table of the artery
(periodic acid Schiff stain, 400 original magnification). The
thrombus is present in the lower left hand side of the picture and
contains a mixture of inflammatory cells, including a prominent
number of eosinophils (arrow). There is early organization along
the endothelial surface, with reactive endothelial nuclei and early
fibroblastic activity. The media (*) is free of inflammation.early organization as well as adventitial inflammation. The
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rently, at 9 months follow-up, she is asymptomatic with
palpable radial and ulnar pulses.
DISCUSSION
Ultimately, most patients with HES are found to have
allergic disease, parasitic infection, immunodeficiency, an
inflammatory process, eosinophilia-myalgia syndrome,
Churg-Strauss syndrome, or malignancy. The patient pre-
sented here had a previous diagnosis of HES. HES was first
described in 1968 by Hardy and Anderson10 and later
defined in 1975 by Chusid et al.11,12 HES is characterized
by an overproduction of eosinophils that leads to organ
damage. Chusid defined HES as the presence of a sustained
eosinophil count of 1500 cells/mL that persists for 6
months without any other obvious cause of eosinophilia.
Patients must have signs and symptoms of organ involve-
ment. In patients without evidence of organ involvement,
the diagnosis of benign eosinophilia is made.10,11
Although the etiology of HES is unclear, there is evi-
dence of T cell clonal proliferation with interleukin-5
(IL-5) hypersecretion. IL-5 plays a role in the differentia-
tion of eosinophils,1 but the pathophysiology of IL-5 and
eosinophilia differentiation is not completely understood.
It is known, however, that eosinophils spend approximately
8 days maturing in the bone marrow before they are re-
leased to the periphery. A variety of transcription factors
within the bonemarrow, includingGATA-1, GATA-2, and
c/EBP, regulate eosinophil production.
In addition to these transcription factors, a variety of
growth factors allow the lineage of eosinophils to mature.
IL-5 induces the production, expansion, and release of
eosinophils from the bone marrow. Multiple animal studies
demonstrate that overproduction of IL-5 leads to hyper-
eosinophilia, whereas a deletion of the IL-5 gene reduces
the number of eosinophils.14-16 Also, food allergies may be
associated with HES, as 75% of patients improve with a
hypoallergenic diet.16
Eosinophils are recruited to sites of inflammation by IL-5
and induced and stimulated by granulocyte-macrophage
colony-stimulating factor. When eosinophils arrive, they
typically undergo degranulation followed by apoptosis.
Compared with neutrophils, eosinophils survive longer in
the tissues. As a result of their longer survival and granule
components, eosinophils are associated with a greater in-
flammatory reaction and chronic reparative changes, partic-
ularly in conditions such as HES. Eosinophils release toxic
cationic proteins, including eosinophil cationic protein
(ECP), eosinophil peroxidase, eosinophil-derived neurotoxin,
major basic protein (MBP), and platelet activating factor.
These granules are particularly toxic against parasites.
In the process of destroying foreign microbes, these
toxins mediate host tissue damage. The effects of hyper-
eosinophilia on the airway are better understood than the
effects on the vascular system. The eosinophilic granulo-
cytes cause contraction of the airway smooth muscle, alter
vascular permeability, and promote mucus secretion. Ulti-mately, these changes lead to respiratory distress. These
types of changes are commonly seen in asthmatic patients.
AlthoughHES frequently causes pulmonary injury, the
heart and gastrointestinal tract are also affected. In refer-
ence to the heart, there are several reports of myocardial
fibrosis, aortic stenosis and congestive heart failure from
HES.1,11,12,17,18 In the gastrointestinal tract, eosinophilia
can cause inflammation of the esophagus, stomach, small
intestine, and colon. These patients often present with
complaints of vomiting, abdominal pain, diarrhea, melena,
or failure to thrive.16
Reports of peripheral vascular occlusion associated with
HES are anecdotal. Stephan et al 9 reported the develop-
ment of Raynaud’s phenomenon with associated hyper-
eosinophilia. As seen in our patient, there was angiographi-
cally documented occlusion of the small and medium arter-
ies of the arm with vasospasm. Others have reported eosin-
ophilic thrombotic occlusion of the portal vein, coro-
nary microvessels, the facial artery, and the occipital
artery.1-3,5,6,8,13,18 There have been several reports docu-
menting coronary artery vasospasm with hypereosino-
philia.19-26 Hertzman et al24 described a woman with
eosinophilia-myalgia syndrome who presented with re-
peated episodes of coronary artery vasospasm. They pro-
posed that eosinophilic secretory products caused arterial
vasospasm.24
Other illnesses such as Buerger’s disease are associated
with highly cellular, thrombotic processes and can present
similarly to our patient. One of the most common aspects
of Buerger’s disease is a substantial smoking history, and
most individuals are from Japan, Israel, and India. Our
patient, however, did not smoke and was from the United
States. Morphologically, the thrombus associated with
Buerger’s disease contains microabscesses with a central
focus of neutrophils. Ultimately, this process entails con-
tiguous involvement of veins and nerves encased in fibrous
tissue.
One case report cannot prove a relationship, causal or
otherwise, between HES and arterial occlusive disease;
however, a confluence of findings support such a relation-
ship. This patient is a young woman with no risk factors or
other evidence of atherosclerotic occlusive disease. She had
an elevated white blood cell count with 38% eosinophils,
eosinophils within the brachial artery specimen, and intense
vasospasm noted on the operative angiogram. Since eosin-
ophils can induce arterial vasospasm, smooth muscle con-
traction, and Raynaud’s phenomenon, we are suggesting
that this type of vasospasm was mediated by hypereosino-
philia that caused chronic arterial changes and eventually
thrombosis. Although HES may be a rare and unusual
disease, the presence of this disease may be a risk factor for
arterial disease.
REFERENCES
1. D’Souza MG, Swistel DG, Castro JL, DeRose JJ Jr. Hypereosinophilic
thrombus causing aortic stenosis andmyocardial infarction. Ann Thorac
Surg 2003;76:1725-6.
JOURNAL OF VASCULAR SURGERY
Volume 42, Number 4 Ponsky et al 7992. Aoki M, Kimura Y, Kusunoki T, Tahara S, Kawanah S. Angiolymphoid
hyperplasia with eosinophilia associated with anomalous dilatation of
occipital artery: IL-5 and VEGF expression of lesional mast cells. Arch
Dermatol 2002;138:982-4.
3. Arnold M, Geilen CC, Coupland SE, Krengel S, Dippel E, Sproder J,
et al. Unilateral angiolymphoid hyperplasia with eosinophilia involving
the left arm and hand. J Cutan Pathol 1999;26:436-40.
4. Aurello P, Cicchini C, D’Angelo F, Di Gioia CR, D’Amati G. Angi-
olymphoid hyperplasia with eosinophilia: a rare artery lesion. Anticancer
Res 2003;23:3069-72.
5. Kimura Y, Tsutsumi T, Kuroishikawa Y, Kishimoto S. Angiolymphoid
hyperplasia with eosinophilia arising from the facial artery. J Laryngol
Otol 2003;117:570-3.
6. Kobayashi H, Moriya T, Tagami H. Protruding tumorous angiolym-
phoid hyperplasia with eosinophilia (ALHE) of the scalp accompanied
by arterial occlusion. J Dermatol 2002;29:38-42.
7. Krapohl BD, Machens HG, Reichert B, Mailander P. A rare vasoprolif-
erative lesion: angiolymphoid hyperplasia with eosinophilia of the hand.
Br J Plast Surg 2003;56:168-70.
8. Sandstad E, Aksnes H, Sund S, Reinholt FP. Recurrent angiolymphoid
hyperplasia with eosinophilia mimicking temporal arteritis associated
with nephrotic syndrome. Clin Nephrol 2003;59:206-11.
9. StephanD, Lipsker D, Sens P,Hassani S,WelschM.Hypereosinophilia-
induced digital necrosis in a smoking patient. Int Angiol 2003;22:95-7.
10. Hardy WR, Anderson RE. The hypereosinophilic syndromes. Ann
Intern Med. Jun 1968;68:1220-9.
11. Chusid MJ, Dale DC, West BC, Wolff SM. The hypereosinophilic
syndrome: analysis of fourteen cases with review of the literature.
Medicine (Baltimore) 1975;54:1-27.
12. Herrin VE, Files JC, Zhou Y, Schick P. Hypereosinophilic syndrome.
Available at: http://www.emedicine.com/med/topic1076.htm. Last
accessed Jul 7, 2005.
13. Kikuchi K, Minami K, Miyakawa H, Ishibashi M. Portal vein thrombo-
sis in hypereosinophilic syndrome. Am J Gastroenterol 2002;97:
1274-5.
14. Bainton D. Developmental biology of neutrophils and eosinophils. In:
Gallin J, Goldstein I, Snyderman R, editors. Inflammation: basic prin-
ciples and clinical correlates, 2nd ed. New York: Raven Press; 1992.
p. 303.15. Gleich G, Adolphson C, Leiferman K. The biology of the eosinophilic
leukocyte. Annu Rev Med 1993;44:85.
16. Rothenberg ME. Eosinophilic gastrointestinal disorders (EGID). J
Allergy Clin Immunol 2004;113:11-28; quiz, 29.
17. Lorenzoni R, Cortigiani L, Melosi A. Cardiac involvement in idiopathic
hypereosinophilic syndrome. Heart 2002;87:553.
18. Terai M, Yasukawa K, Honda T, Jibiki T, Hirano K, Sato J, et al.
Peripheral blood eosinophilia and eosinophil accumulation in coronary
microvessels in acute Kawasaki disease. Pediatr Infect Dis J 2002;21:
777-81.
19. Gersh BJ, Bassendine MF, Forman R, Walls RS, Beck W. Coronary
artery spasm and myocardial infarction in the absence of angiographi-
cally demonstrable obstructive coronary disease. Mayo Clin Proc 1981;
56:700-8.
20. Takagi S, Goto Y, Hirose E, Terashima M, Sakuragi S, Suzuki S, et al.
Successful treatment of refractory vasospastic angina with corticoste-
roids: coronary arterial hyperactivity caused by local inflammation? Circ
J 2004;68:17-22.
21. Horigome H, Sekijima T, Ohtsuka S, Shibasaki M. Life threatening
coronary artery spasm in childhood Kimura’s disease. Heart 2000;84:E5.
22. Okada H, Koganei H, Yoshioka S, Enta K, Suzuki K, Kato J, et al.
[Multi-vasospastic angina refractory to medical therapy caused by hy-
perthyroid stage of chronic thyroiditis and hypereosinophilia: a case
report]. J Cardiol 2000;35:189-96.
23. Takahashi N, Kondo K, Aoyagi J. Acute myocardial infarction associ-
ated with hypereosinophilic syndrome in a young man. Jpn Circ 1997;
61:803-6.
24. Hertzman PA, Maddoux GL, Sternberg EM, Heyes MP, Mefford IN,
Kephart GM, et al. Repeated coronary artery spasm in a young woman
with the eosinophilia-myalgia syndrome. JAMA 1992;267:2932-4.
25. Kounis NG, Zavras GM.Histamine-induced coronary artery spasm: the
concept of allergic angina. Br J Clin Pract 1991;45:121-8.
26. Hirakawa Y, Koyanagi S, Matsumoto T, Takeshita A, Nakamura M. A
case of variant angina associated with eosinophilia. Am J Med 1989;87:
472-4.Submitted Mar 17, 2005; accepted May 31, 2005.
